Pharmaceutical pollution: The medicines we take to stay healthy are harming nature
May
Evidence is mounting that modern medicines present a growing threat to ecosystems around the world. The chemicals humans ingest to stay healthy are harming fish and other animals.
Modern pharmaceuticals have revolutionised disease prevention and treatment. But after our bodies use medicines, they excrete them. Eventually, the chemicals can end up in rivers, oceans and soils.
This is a problem, because medicines designed to treat humans can also affect other species in serious ways, changing their bodies and behaviour. The chemicals can also pass through food webs and affect animals higher up the chain.
Urgent action is needed to design drugs that work on humans, but don’t harm nature.
Evidence of harm
In the past two decades, studies have emerged showing the extent to which medicines persist in nature.
In August 2024 year, Australian researchers found the antidepressant fluoxetine – sold under the brand name Prozac, among others – can harm male guppies in ways that affected their body condition and breeding.
Research in 2022 examined pharmaceuticals in rivers in 104 countries of all continents. It found pharmaceutical contaminants posed a threat to the health of the environment or humans in more than a quarter of locations studied.
In 2018, a study of watercourses and surrounds in Melbourne found more than 60 pharmaceutical compounds in aquatic invertebrates and spiders.
Researchers in the United States have found hormones in the contraceptive pill have caused male fish to produce a protein usually produced by female fish. This “feminisation” led to collapses in fish populations.
And a psychoactive drug found in wastewater effluent has been found to alter wild fish behaviour and feeding.
Benign by design
So how do we solve this problem?
More effective and economical wastewater treatments must be developed to remove pharmaceuticals from wastewater before it’s discharged into the environment.
In addition, researchers developing pharmaceuticals must adopt a “benign by design” approach across the entire life of a drug.
From the outset, drugs must be designed to decompose quickly and fully after being excreted by humans. It’s possible for drug scientists to alter the chemical and physical properties of drugs so after humans excrete them, the active ingredients mineralise, or change form, to base substances such as carbon dioxide and water.
Traditionally, researchers have designed drugs not to break down, either on the shelf or in the human body. While these properties remain important, drug developers should ensure medicines degrade quickly once in the environment.
Taking action
The principles of sustainable drug discovery should be included in Australia’s academic curriculum.
This would hopefully produce a generation of drug researchers who prioritise, where possible, medications that don’t harm the environment.
Regulation is also needed to ensure “greener” drug development. The International Pharmaceutical Federation last year took steps in this direction. The global body, representing more than four million pharmacists and pharmaceutical scientists, released a statement calling for all medicines to be rigorously tested for environmental risk.
The European Medicines agency has gone even further. It requires the environmental risk of a medicine to be assessed before it’s approved for use.
The assessment considers a medicine’s chemical properties, potential ecological harm, and where in the environment it may end up, such as water or soil. Pharmaceutical companies are also required to produce waste management plans that minimise environmental impact.
Research has found Australia lags behind on introducing similar requirements for environmental risk assessments for medicines.
By prioritising eco-friendly practices, the pharmaceutical sector can contribute to a healthier planet, while continuing to provide safe and effective medicines.
Everyday Australians can also take action to reduce environmental pollution from medicines. The federal government’s Return Unwanted Medicines project allows household drugs to be returned to pharmacies for safe and correct disposal.
By dropping off old medicines to your local chemist – instead of flushing or throwing them away, as some people mistakenly do – you can help look after fish and other wildlife in your area.
This article originally appeared on The Conversation.
About the Authors
-
Lauren may
Heart Foundation Future Leader Fellow, and Co-lead, GPCR Cardiac Biology Laboratory, Monash Institute of Pharmaceutical Sciences
Lauren uses her molecular pharmacology expertise to apply new and innovative GPCR drug discovery approaches for the development of safe and effective cardiovascular therapeutics. As the recipient of the 2018 Heart Foundation Paul Korner Innovation Award, Lauren was endorsed for pushing boundaries with the most innovative Future Leader Fellowship. She is an advocate for ensuring more diverse voices in science, co-founder & co-chair of Her Research Matters, a member of the 2019 International Women’s Forum (IWFA) Emerging Leaders Cohort and as a supervisor she aims to empower the careers of her PhD mentees.
-
Manuela jorg
Research Fellow, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences
Manuela started her career with an apprenticeship as a chemical lab technician at Ciba Specialty Chemicals. After a few years working in industry, she obtained a bachelor and master degrees in chemistry from the University of Applied Sciences Northwestern Switzerland and the University of Basel, respectively. While being interested and trained as an organic chemist, she’s has always been passionate about the application of chemistry within the health sciences. Therefore, for her PhD she specialised in medicinal chemistry, with the aim to contribute to improving health within our society. Manuela is a lab head in the medicinal chemistry theme at the Monash Institute of Pharmaceutical Sciences, where her research interests are in the development of chemical probes and small molecule drugs.
Other stories you might like
-
Fish on Prozac: Chemical residues in wastewater mess with bodies, behaviour and sperm
New research reveals how water containing the antidepressant Prozac affects male guppies, raising concerns about the health of aquatic ecosystems exposed to pharmaceutical pollution.
-
Changing course on climate
Healthcare education is in need of a major overhaul if it's to address the sector’s climate change impact.
-
Taking to the water
Researchers are using the environmental DNA sampling method to effectively assess animal populations in bushfire-affected areas.
-
Drugs and bugs: what's lurking in our waterways
New research shows that medicines have found their way into Melbourne streams – and the creatures that live in them.